|
AU9139101A
|
|
Novel anti-viral compounds
|
|
AU5318101A
|
|
Expression system for efficiently producing clinically effective lysosomal enzymes (glucocerebrosidase)
|
|
EP1257665A2
|
|
LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION
|
|
WO0145836A2
|
|
Molecules derived from mechanism based drug design
|
|
CA2379676A1
|
|
Method of designing tubulin polymerization stabilizers
|
|
AU4031100A
|
|
Fungal beta-tubulin genes
|
|
US6117981A
|
|
Hybridomas for lung cancer marker and monoclonal antibodies thereof
|
|
WO9844096A2
|
|
Mycobacterium recombinant vaccines
|
|
WO9512675A1
|
|
A fusion protein and method for making and using same
|
|
US5589579A
|
|
Gene sequence and probe for a marker of non-small cell lung carinoma
|
